Skip to content

MLAB · NASDAQ

Mesa Laboratories (MLAB) Stock Price & Fundamentals

$524.94−0.34%−$1.81End-of-day price as of Oct 9, 2026

Mesa Laboratories (MLAB) closed at $524.94 on Oct 9, 2026, down 0.34% from the previous close of $526.75.

Share price, past year

1Y +1.65%

52-week range $493.02 – $558.81. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$524.94
Sep 30, 2026$530.78
Aug 31, 2026$537.02
Jul 31, 2026$512.38
Jun 30, 2026$542.54
May 29, 2026$541.53
Apr 30, 2026$512.71
Mar 31, 2026$498.36
Feb 27, 2026$522.75
Jan 30, 2026$517.90
Dec 31, 2025$526.12
Nov 28, 2025$509.88
Oct 31, 2025$535.33

Key statistics

Market cap
$2.94B
P/E (TTM)
617.6
EPS (TTM)
$0.85
Revenue (TTM)
$249.73M
Net income (TTM)
$4.80M
Shares outstanding
5.6M
Dividend yield
—
52-week range
$493.02 – $558.81

Mesa Laboratories's market cap is $2.94B, based on a share price of $524.94 and 5.6M shares outstanding as of Jun 30, 2026.

Financials

Mesa Laboratories reported revenue of $249.13M for fiscal 2026, up 3.38% from fiscal 2025.

Mesa Laboratories earned net income of $6.71M in fiscal 2026, a net margin of 2.7%.

Fiscal 2026 revenue was the highest in the 10 years shown.

Annual revenue

FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Annual revenue by fiscal year; the table below lists the values.
Mesa Laboratories annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2026ended Mar 31, 2026$249.13M+3.4%$6.71M2.7%$1.21$39.58M
FY2025ended Mar 31, 2025$240.98M+11.5%−$1.97M−0.8%−$0.36$42.56M
FY2024ended Mar 31, 2024$216.19M−1.3%−$254.25M−117.6%−$47.20$41.57M
FY2023ended Mar 31, 2023$219.08M+18.9%$930.00K0.4%$0.17$23.44M
FY2022ended Mar 31, 2022$184.34M+37.6%$1.87M1.0%$0.35$34.79M
FY2021ended Mar 31, 2021$133.94M+13.8%$3.27M2.4%$0.64$35.08M
FY2020ended Mar 31, 2020$117.69M+14.1%——$0.41$25.49M
FY2019ended Mar 31, 2019$103.14M+7.2%——$1.86$29.29M
FY2018ended Mar 31, 2018$96.18M+2.7%——−$0.79$22.92M
FY2017ended Mar 31, 2017$93.67M———$2.91—
Mesa Laboratories quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q1 FY2027ended Jun 30, 2026$60.14M$2.83M$0.49
Q4 FY2026ended Mar 31, 2026$63.72M−$4.14M−$0.74
Q3 FY2026ended Dec 31, 2025$65.13M$3.63M$0.65
Q2 FY2026ended Sep 30, 2025$60.74M$2.48M$0.45
Q1 FY2026ended Jun 30, 2025$59.54M$4.74M$0.85
Q4 FY2025ended Mar 31, 2025$62.14M−$7.11M−$1.30
Q3 FY2025ended Dec 31, 2024$62.84M−$1.68M−$0.31
Q2 FY2025ended Sep 30, 2024$57.83M$3.43M$0.63

Company profile

Name
Mesa Laboratories, Inc.
Ticker
MLAB
Exchange
NASDAQ
Industry (SEC SIC)
Industrial Instruments For Measurement, Display, and Control
Headquarters
12100 W 6th Ave, Lakewood, CO 80228
Incorporated in
CO
Fiscal year ends
March
SEC CIK
0000724004

Recent SEC filings

Frequently asked questions

What is Mesa Laboratories's stock price?

Mesa Laboratories (MLAB) closed at $524.94 on Oct 9, 2026, down 0.34% from the previous close of $526.75.

What is Mesa Laboratories's market cap?

Mesa Laboratories's market cap is $2.94B, based on a share price of $524.94 and 5.6M shares outstanding as of Jun 30, 2026.

How much revenue does Mesa Laboratories make?

Mesa Laboratories reported revenue of $249.13M for fiscal 2026, up 3.38% from fiscal 2025.

What is MLAB's P/E ratio?

Mesa Laboratories's price-to-earnings ratio is 617.6, based on trailing twelve-month diluted EPS of $0.85.

Does Mesa Laboratories pay a dividend?

Mesa Laboratories's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Mesa Laboratories, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures